More tools:Markets·Screener·Research·Chat

Eupraxia Pharmaceuticals Inc. Common Stock (EPRX) Financial Statements

Eupraxia Pharmaceuticals Inc. Common Stock
SIC 8099 · PHARMACEUTICAL PREPARATIONS
FIGI BBG00Z83VS56
XNAS · usd
8.19▼ 0.06 (-0.76%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales—
EV / Revenue—
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close8.25
Day's Range8.22 – 8.60
52-Week Range5.15 – 9.32
Volume373.6K
Avg Volume483.7K
Share Statistics
Shares Outstanding
Employees49
ExchangeXNAS
Listed2021-06-09
Share count as of December 31, 2025
Loading Income Statement…
Key questions about Eupraxia Pharmaceuticals Inc. Common Stock (EPRX)
What is Eupraxia Pharmaceuticals Inc. Common Stock's Market Cap?
Eupraxia Pharmaceuticals Inc. Common Stock's Market Cap is $493.6M, based on as-reported figures from SEC (XBRL) filings.
What is Eupraxia Pharmaceuticals Inc. Common Stock's Enterprise Value?
Eupraxia Pharmaceuticals Inc. Common Stock's Enterprise Value is $413.1M, based on as-reported figures from SEC (XBRL) filings.
What is Eupraxia Pharmaceuticals Inc. Common Stock's EV / EBITDA?
Eupraxia Pharmaceuticals Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Eupraxia Pharmaceuticals Inc. Common Stock's Revenue (TTM)?
Eupraxia Pharmaceuticals Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Eupraxia Pharmaceuticals Inc. Common Stock's Net Income (TTM)?
Eupraxia Pharmaceuticals Inc. Common Stock's Net Income (TTM) is -$41.1M, based on as-reported figures from SEC (XBRL) filings.
What is Eupraxia Pharmaceuticals Inc. Common Stock's EBITDA?
Eupraxia Pharmaceuticals Inc. Common Stock's EBITDA is -$38.3M, based on as-reported figures from SEC (XBRL) filings.
What is Eupraxia Pharmaceuticals Inc. Common Stock's Diluted EPS (TTM)?
Eupraxia Pharmaceuticals Inc. Common Stock's Diluted EPS (TTM) is -0.68, based on as-reported figures from SEC (XBRL) filings.
What is Eupraxia Pharmaceuticals Inc. Common Stock's Net Debt?
Eupraxia Pharmaceuticals Inc. Common Stock's Net Debt is -$80.6M, based on as-reported figures from SEC (XBRL) filings.
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022
Expenses
General and administrative
Research and development
Total expenses
Other income/(expenses)
Interest income
Interest expense
Gain (loss) on sale of equipment
Foreign exchange gain (loss)
Convertible debt costs
Change in fair value of financial instruments
Total other income/(loss)
Loss before tax expense
Tax expense
Net loss for the year
Loss attributable to:
Owners of the Company
Non-controlling interest
Net loss for the year
Loss per share – basic
Loss per share – diluted